Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
42.90
-0.23 (-0.53%)
Nov 17, 2026, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 17.05 billion as of November 16, 2026. It is the 5,483rd most valuable company in the world and the 871st biggest in China. Its market cap has decreased by 46.36% in one year.
Market Cap
17.05B
Enterprise Value
17.01B
Revenue
3.95B
Global Rank
Country Rank
#871 China
PE Ratio
20.91
ChartMarket Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 17.05B, an increase of 18.71%. That is a compound annual growth rate of 2.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 17.05B | -50.09% |
| Dec 31, 2025 | 34.16B | 14.44% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 22.51B |
| Hualan Biological Engineering | 21.51B |
| Hebei Changshan Biochemical Pharmaceutical | 17.18B |
| Yili Chuanning Biotechnology | 16.99B |
| Evopoint Biosciences | 15.67B |
| HitGen | 15.43B |
| Acrobiosystems | 14.02B |
| Sinocelltech Group | 13.95B |